Male 04
Natural health product licensed in Canada
- Licence holder
- Stalco Inc.
- NPN or DIN-HM
- 80089191
- Status
- Inactive licence
- Licence date
- 15 November 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Lepidium meyenii Walp.: L'absence d'alcaloïdes doit être démontrée par des rapports d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lepidium meyenii Source : Racine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 1,000 mg | 100 mg | Not calculated |
| Ginkgo biloba Source : Feuille Extract : Matériel brut sec Extraction ratio : 50:1 Dry plant equivalent : 1,500 mg Potency : 6 % Terpene lactones | 30 mg | Not calculated |
| L-arginine Source : Monohydrochlorure de L-arginine | 25 mg | Not calculated |
| Ginkgo biloba Source : Feuille Potency : 24 % Flavonoid glycosides | Not specified | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe masculin | Not specified | 1 Capsule | 3 days |
Uses authorised in Canada
Maca helps to support emotional aspects of sexual health and provides antioxidants. Panax ginseng helps support cognitive function and reduce mental fatigue. Panax ginseng is used in Herbal Medicine to help enhance physical capacity/performance. Magnesium helps to maintain proper muscle function. Ginkgo biloba helps to support peripheral circulation. Ashwagandha is traditionally used in Ayurveda as Rasayana (rejuvenative tonic). Magnesium helps the body to metabolize carbohydrates, proteins and fats. Magnesium helps in tissue formation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Some people may experience insomnia, anxiety, or headaches, in which case, discontinue use.
- Contre-indications
Do not use if you are taking health products that affect blood coagulation (e.g. blood thinners, clotting factor replacements, acetylsalicylic acid, ibuprofen, fish oils, vitamin E) as this may increase the risk of spontaneous bleeding.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are taking digoxin or medication for depression, diabetes, high blood pressure, or seizures. Consult a health care practitioner prior to use if you have high blood pressure, diabetes, or if you suffer from any psychological disorder and/or condition such as frequent anxiety or depression. Consumption with alcohol, other drugs or natural health products with sedative properties is not recommended.
Source
Official Health Canada record, licence 80089191
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.